Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1352517

registered interest
date	03/09/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, how many doses of covid-19 vaccine the UK has received from Covax for each month since Covax has been in operation; for what reasons the UK has received doses through Covax; and if he will make a statement.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	41806
answer	answer is ministerial correction date of answer 13/09/2021 answer text <p>The UK committed approximately £71 million to the self-financing facility of COVAX, which enables high and upper-middle income countries to pool investments in potential vaccine candidates, and supported its establishment last year. This gives us the option to buy vaccines for up to 20% of the UK population - approximately 27 million doses. The Government has separately committed £548 million to the COVAX Advance Market Commitment, which will distribute 1.2 billion doses of vaccines to developing countries this year.</p><p> </p><p>In addition, I am proud that as part of our commitment to the G7 to donate 100m doses over the course of the next year, the UK has so far donated over 10 million doses to those countries most in need, of which over 6 million have gone to COVAX. Throughout the COVID-19 vaccination programme, vaccine supply and deliveries have been carefully managed by the Vaccine Taskforce to meet the requirements of the domestic vaccination programme as well as support other countries’ domestic campaigns. The recent sharing of 4 million doses with Australia is a good example of this.</p><p> </p><p>I refer the Hon. Member to the answer I gave her on 3rd March 2021 to Question <a href="https://questions-statements.parliament.uk/written-questions/detail/2021-02-23/157070" target="_blank">157070</a>: the UK procured approximately 0.5 million doses of the Pfizer vaccine through COVAX, which were delivered earlier this year. These doses helped the NHS deliver our vaccination programme as quickly as possible. No further doses have been received by the UK from COVAX.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/09/2021 13:04:33 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3930 label Biography information for Caroline Lucas

1349284

registered interest
date	21/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make it his policy to include unpaid carers and adult household contacts of clinically extremely vulnerable people on the priority list for a booster covid-19 vaccine; and if he will make a statement.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	37420
answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation’s (JCVI) interim advice is that COVID-19 booster vaccinations should first be offered to the most vulnerable.</p><p>The JCVI’s interim advice recommends a two-staged approach, with individuals in stage one offered a booster vaccine as well as a flu vaccine, as soon as possible from September 2021. Individuals in stage two offered a booster vaccine as soon as practicable after stage one, with equal emphasis on deployment of the flu vaccine where eligible. The JCVI advises that unpaid carers and the adult household contacts of immunosuppressed individuals should be offered a COVID-19 booster vaccine.</p><p>Final decisions on the timing and scope and cohort eligibility of any COVID-19 vaccine booster programme will be confirmed once the JCVI has provided their final advice.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 11:48:51 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3930 label Biography information for Caroline Lucas

1346422

registered interest
date	13/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 12 July 2021 to Question 25974 on Arthritis: Coronavirus, whether he plans to publish the results of the OCTAVE study on covid-19 vaccine response in people with impaired immune systems before Step 4 of the roadmap for lifting covid-19 restrictions; and if he will make a statement.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	32348
answer	answer is ministerial correction date of answer 23/07/2021 answer text <p>We recognise the importance of this study. UK Research and Innovation, the Department and the OCTAVE study team are preparing a pre-print paper for publication shortly.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 23/07/2021 14:00:36 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 15296 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3930 label Biography information for Caroline Lucas

1344201

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) monitor covid-19 vaccination rates and (b) increase vaccine uptake among people who are homeless; if he will publish data to support vaccine uptake among homeless people; and if he will make a statement.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	28141
answer	answer is ministerial correction date of answer 22/07/2021 answer text <p>People who are experiencing homelessness were prioritised for vaccination in phase one of the programme alongside those with underlying health conditions, as advised by the Joint Committee on Vaccination and Immunisation (JCVI). To ensure access, we have followed the JCVI recommendation that this group should be offered the vaccine without the need for a National Health Service number or general practitioner registration.</p><p>Vaccination rates amongst the homeless population is monitored at a regional level within England and is used to inform deployment decisions so that uptake is maximised where possible. Data on vaccination uptake is not currently available as it has not been centrally validated. This is because data provides a snapshot of homelessness rates and as such, any vaccine uptake data relating to homeless people and COVID-19 vaccination uptake is also an estimate that cannot currently be validated. NHS England and NHS Improvement continue to work with the Ministry of Housing, Communities and Local Government to support outreach services and further work is being done to explore the availability of effective on-street models. Local vaccination services also play a vital role in reaching vulnerable groups, including people experiencing homelessness.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 28237 question first answered 22/07/2021 14:28:05 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3930 label Biography information for Caroline Lucas

1339938

registered interest
date	24/06/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what estimate he has made of the number of doses of covid-19 vaccines the UK will take receipt of in (a) 2021 and (b) 2022; and of those does, what estimate he has made of the number that will be needed for domestic use in each of those years.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	21859
answer	answer is ministerial correction date of answer 01/07/2021 answer text <p>Vaccines are a precious resource and are in very high demand across the world; therefore, for security reasons it is not possible to provide detail about the size of our supplies or give exact detail about future deliveries.</p><p> </p><p>The UK Government has secured early access to 397 million vaccine doses through supply agreements with six separate vaccine developers, of which four have received regulatory approval and three are currently in deployment. This includes agreements with:</p><ul><li>Pfizer/BioNTech for 100 million doses</li><li>University of Oxford/AstraZeneca for 100 million doses</li><li>Moderna for 17 million doses</li><li>Novavax for 60 million doses</li><li>Janssen for 20 million doses</li><li>Valneva for 100 million doses</li></ul><p>In addition, the Government has a reservation agreement with GlaxoSmithKline/Sanofi Pasteur for 60 million doses and a non-binding agreement with CureVac for 50 million doses.</p><p> </p><p>We do not yet know how long vaccines will provide protection against Covid-19. For this reason, the Government is developing a plan for a vaccine booster campaign to protect against a resurgence of the virus in winter 2021/22. The final decision on what a booster programme will look like – and the cohorts included - will depend on the data from ongoing clinical trials, such as the COV-Boost trial, and advice from the independent medical experts at the JCVI. For this reason, we are currently unable to specify final dose numbers that may be required for 2021 and 2022.</p><p> </p><p>However, as announced by my Rt. Hon. Friend the Prime Minister ahead of the G7 Summit, the UK has committed to donating 5 million vaccine doses, primarily through COVAX by the end of September 2021, for use in the world’s poorest countries. The Prime Minister has also committed to making a total of 100 million doses available within the next year, including a total of 30 million by the end of 2021.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 01/07/2021 14:16:10 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3930 label Biography information for Caroline Lucas

1339939

registered interest
date	24/06/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what estimate he has made of the total cost of covid-19 vaccines the UK is planning to receive in (a) 2021 and (b)2022 broken down by manufacturer.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	21860
answer	answer is ministerial correction date of answer 01/07/2021 answer text <p>We are not able to disclose details of commercially sensitive contracts between the Government and vaccine manufacturers.</p><p> </p><p>At the Comprehensive Spending Review 2020, the Government announced that more than £6 billion has been made available to develop, manufacture, and procure COVID-19 vaccines.</p><p> </p><p>We have secured early access to 397 million vaccine doses through supply agreements with six separate vaccine developers, of which four have received regulatory approval and three are currently in deployment. This includes agreements with:</p><p> </p><ul><li>Pfizer/BioNTech for 100 million doses</li><li>University of Oxford/AstraZeneca for 100 million doses</li><li>Moderna for 17 million doses</li><li>Novavax for 60 million doses</li><li>Janssen for 20 million doses</li><li>Valneva for 100 million doses</li></ul><p> </p><p>In addition, the Government has a reservation agreement with GlaxoSmithKline/Sanofi Pasteur for 60 million doses and a non-binding agreement with CureVac for 50 million doses.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 01/07/2021 14:14:53 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3930 label Biography information for Caroline Lucas

1340051

registered interest
date	24/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Answer of 10 June 2021 to Question 10529, what recent advice he has received from (a) the Joint Committee on Vaccination and Immunisation (JCVI) and (b) other experts on whether the Pfizer/BioNTech vaccine should be offered to children aged 12 to 15 years who are (i) clinically extremely vulnerable and shielding, (ii) clinically extremely vulnerable and who meet two of the three current Green Book criteria of (A) severe neurodisabilities, (B) recurrent respiratory infections and (C) frequent stays in specialist residential settings and (iii) clinically extremely vulnerable; and when he plans to provide information to affected children and families.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	21869
answer	answer is ministerial correction date of answer 29/06/2021 answer text <p>The Joint Committee on Vaccination and Immunisation is examining the evidence and the relative risks and benefits of vaccinating children and young people and will provide advice to the Government in due course.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 29/06/2021 15:20:10 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3930 label Biography information for Caroline Lucas

1330807

registered interest
date	08/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to increase covid-19 vaccination rates in areas where those rates are consistently lower than average; what assessment he has made of the reasons for lower take-up rates of that vaccination in those areas; if he will make it his policy to tailor plans to tackle covid-19 vaccination take-up so that those plans accurately reflect the reasons for lower than average vaccination take-up in specific areas; and if he will make a statement.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	12106
answer	answer is ministerial correction date of answer 06/07/2021 answer text <p>Assessment of local vaccination rates is led by National Health Service teams. This data is shared daily with local authority Directors of Public Health to identify emerging trends and prevent any developing inequalities locally. Qualitative information about the reasons for vaccine refusal is also collected.</p><p> </p><p>We are working across Government to consider how best to maximise vaccine uptake. A range of information and advice via TV, radio, and social media is targeted in areas with lower vaccination rates.</p><p> </p><p>On 10 June 2021, NHS England and NHS Improvement announced £20 million for vaccination sites across the country to increase staffing, boost uptake and ensure equal access.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/07/2021 12:13:49 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3930 label Biography information for Caroline Lucas

1329018

registered interest
date	27/05/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to reach a decision on covid-19 booster vaccinations; by what date guidance on that matter will be issued to NHS delivery teams for planning purposes; how much time he plans to provide for local planning ahead of a booster campaign; and if he will make a statement.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	8572
answer	answer is ministerial correction date of answer 10/06/2021 answer text <p>To ensure ongoing protection from COVID-19 for the United Kingdom population, we are working closely with NHS England on preparing for a potential booster vaccination programme from the autumn. Whilst we are planning for several potential scenarios, final decisions on the timing and scope of the booster programme in terms of when to give boosters to which groups and with which vaccines will not be taken until later this year.</p><p> </p><p>Any decision on a booster vaccination programme will be informed by independent advice from the Joint Committee for Vaccination and Immunisation (JCVI). The JCVI will review the emerging scientific evidence, alongside data supplied by manufacturers, to inform the Government in our decision-making process on when to give boosters to which groups and with which vaccines.</p><p> </p><p>We are continuing to work closely with NHS England to support regions and local systems with planning to ensure we are prepared to begin the rollout of any booster programme.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/06/2021 15:51:49 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3930 label Biography information for Caroline Lucas

1329020

registered interest
date	27/05/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the resources that (a) GPs and (b) other bodies will require to deliver a booster vaccination programme against covid-19 in the autumn of 2021; and if he will make a statement.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	8574
answer	answer is ministerial correction date of answer 17/06/2021 answer text <p>The Department and NHS England are working closely with regional and local systems to ensure we have the appropriate resourcing available for a potential booster campaign. Whilst we are planning for several potential scenarios, final decisions on the timing and scope of the booster programme will not be taken until later this year, in line with results from key clinical studies and advice from the Joint Committee on Vaccination and Immunisation.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 17/06/2021 15:28:29 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3930 label Biography information for Caroline Lucas